CardiAQ Valve Technologies (CVT) Offers New Hope for Cardiovascular Medicine  
6/19/2012 7:40:17 AM

Nearly 50% of patients suffering from a diseased mitral heart valve with severe, symptomatic regurgitation are denied open-heart surgery because it is considered too risky; in the future, Transcatheter Mitral Valve Implantation (TMVI) may offer new hope for these patients.